34Indexed trials
mesh condition
Brain Neoplasms
Intelligence
Brain Neoplasms intelligence: 34 indexed trials, 8 recruiting studies, 29 sponsors across 24 countries.
8Recruiting
29Sponsors
24Countries
Leading sponsors
St. Jude Children's Research Hospital20 recruiting
National Cancer Institute (NCI)20 recruiting
NeuroVita Clinic20 recruiting
Annick Desjardins20 recruiting
Duke University20 recruiting
Costas Hadjipanayis11 recruiting
INSYS Therapeutics Inc10 recruiting
Colombian Foundation for Epilepsy and Neurological Disease10 recruiting
Fondazione Policlinico Universitario Agostino Gemelli IRCCS10 recruiting
Eli Lilly and Company10 recruiting
Children's Hospital of Fudan University11 recruiting
DelMar Pharmaceuticals, Inc.10 recruiting
Geographic activity
United States19trials
Germany4trials
Netherlands3trials
Austria2trials
Canada2trials
China2trials
Hong Kong2trials
Israel2trials
Italy2trials
Russia2trials
Colombia1trials
Spain1trials
Leading interventions
Dendritic vaccine, allogeneic hematopoietic stem cells, cytotoxic lymphocytes2trials
Dendritic vaccine, autologous hematopoietic stem cells, cytotoxic lymphocytes2trials
Awake craniotomy1trials
Bevacizumab1trials
Carboplatin1trials
Clevidipine1trials
Cognitive Training1trials
Cognitive Assessment1trials
Computerized working memory training program (control)1trials
Computerized working memory training program (intervention)1trials
Craniotomy under general anesthesia1trials
Best Standard of Care1trials
Methodology note
This entity is derived from structured ClinicalTrials.gov conditions and/or MeSH normalization. Counts reflect the current NeuroRisk indexed corpus and are not guaranteed exhaustive global totals.